National Director, Research and Programs
Phone: (240) 235-2215
CureSearch for Children’s Cancer Announces Research Award Opportunities
Up to $7 million in research awards will accelerate the development of better, less-toxic children’s cancer treatments
Bethesda, MD – October 5, 2018 – CureSearch for Children’s Cancer announced a request for applications (RFA) for high potential projects that address areas of unmet need in pediatric cancer, including high-risk, relapsed, or metastatic disease, adolescent and young adult patient populations, and/or the use of novel immunotherapy targets or modalities.
The awards will support revolutionary research and address all stages of the pediatric drug development pipeline, including:
- Young Investigators Award: Provides seed funding for bright researchers, early in their careers, pursuing exciting and novel research in pediatric oncology.
- Acceleration Initiative Award: Funds scientific or technological innovation with the highest likelihood of identifying a breakthrough in childhood cancer treatments and becoming an impactful therapeutic option for children in the near term.
- Catapult Award: Supports the advancement of clinical research to improve outcomes for pediatric cancer patients.
The application window opened Monday, October 5, 2018 via ProposalCENTRAL; award notifications will be released in March 2019. For more information about the CureSearch research award programs visit www.curesearch.org/CureSearch-RFAs.
CureSearch’s mission to end children’s cancer includes supporting researchers through funding, guidance, knowledge and relationships to ensure the greatest chance of success. Funds raised by CureSearch partners, supporters and programs are put toward accelerated research projects with the highest potential. By encompassing all stages of the drug development continuum, CureSearch’s research programs drive pediatric research to the children who need it the most.
About CureSearch for Children’s Cancer
CureSearch for Children’s Cancer, a national nonprofit organization based in Bethesda, MD, works to end childhood cancer by driving targeted and innovative research with measurable results in an accelerated time frame. CureSearch focuses on advancing the strongest research out of the laboratory and into clinical trials and development, where better, less-toxic treatments can quickly help children. For more information, visit curesearch.org, follow CureSearch on Twitter @curesearch or join the conversation on Facebook at www.facebook.com/curesearch.